CHARLOTTE, N.C., US: Dentsply Sirona has introduced the appointment of Daniel Scavilla as president and CEO, efficient from 1 August. Scavilla, an skilled government who has labored for greater than 30 years within the scientific era and pharmaceutical industries, lately serves at the corporate’s board of administrators. He’ll be successful Simon Campion, who will step down on 31 July.
Scavilla maximum lately served as president and CEO of Globus Scientific, the place he led the USA$3 billion (€2.76 billion*) acquisition of NuVasive and the mixing of the 2 organisations into the arena’s second-largest backbone era corporate. His tenure at Globus Scientific incorporated roles as leader monetary officer (CFO), government vp, leader business officer and president of trauma, the place he expanded production and distribution operations and introduced the orthopaedics and trauma department.
Gregory T. Lucier, chairman of the board at Dentsply Sirona, stated: “Dan’s appointment as CEO underscores the board’s sturdy and unwavering dedication to handing over enhanced worth to shareholders and positioning Dentsply Sirona for long term luck. Dan is a seasoned healthcare veteran, and we’re assured that his 3 many years of government management revel in and disciplined focal point on business expansion, product innovation, and fiscal and operational excellence make him neatly suited to guide the corporate into its subsequent bankruptcy. There’s vital untapped alternative around the dental marketplace, and we imagine that Dan is the suitable chief to assist boost up the corporate’s trade transformation, reposition Dentsply Sirona as an trade chief and ship long-term worth advent.”
Scavilla commented: “Dentsply Sirona is a corporation that I’ve admired for its depended on manufacturers, and because becoming a member of the board in February, I’ve won a good deeper appreciation for the large attainable of our trade, folks and merchandise. As I step into the CEO function, I look ahead to operating with the workforce to proceed the corporate’s transformation and power sustained successful expansion and reinforce worth for all stakeholders.”
Campion, who may be stepping down from the board, expressed self belief within the transition: “It’s been a privilege to guide the corporate. We’ve got constructed a robust basis, and I’m assured Dentsply Sirona will thrive underneath Dan’s management.”
Scavilla will proceed as a board director, however will now not serve at the audit and finance committee.
Contemporary management traits
Scavilla’s appointment follows different vital adjustments in Dentsply Sirona’s management. In June, the corporate appointed Matthew E. Garth as government vp and CFO. Garth become the 5th particular person to carry the CFO function—intervening time or everlasting—in 5 years.
In an interview with Dental Tribune Global at this yr’s Global Dental Display, Campion showed that bringing Scavilla and Michael Barber directly to the board used to be a part of the corporate’s ongoing transformation: “Mike and Dan are two confirmed leaders with talent units which can be additive to the board. We accomplished significant growth on our transformation adventure by means of finishing key projects and milestones in 2024, and our momentum continues into 2025 to form the organisation, power efficiencies and allow funding.”
Editorial be aware:
* Calculated at the OANDA platform for 1 September 2023.
Tags:
Are living webinar
Wed. 17 September 2025
10:00 am EST (New York)

Dr. Jana Huttenlau med. dent.
Are living webinar
Wed. 10 December 2025
1:00 pm EST (New York)
Dr. Leander Benz
Prof. Dr. Diana Wolff
Prof. Dr. Diana Wolff
PD Dr. Jörg Tchorz

Prof. Dr. Thomas Attin
Prof. Dr. Diana Wolff
:sharpen(level=0):output(format=jpeg)/up/dt/2025/07/Dentsply-Sirona-names-Daniel-Scavilla-as-new-CEO.jpg?w=750&resize=750,375&ssl=1)


